Background Dysphagia is common in Parkinson's disease (PD). The effects of
antiparkinsonian drugs on dysphagia are controversial. Several treatments for dysphagia …

Background: Drug efficacy generally varies with different durations. There is no systematic
review analyzing the effect of selegiline for Parkinson's disease (PD) on different treatment …

A clinical practice guideline on Parkinson disease was developed by an American Physical
Therapy Association volunteer guideline development group that consisted of physical …

Alzheimer's disease (AD) and Parkinson's disease (PD) are neurodegenerative diseases
(NDD) characterized by progressive degeneration of the central nervous system, and few …

Parkinson's disease (PD) is a common degenerative disease of the central nervous system.
Although some drugs can alleviate the progress of PD, their long-term use will lead to …

Purpose: Dysphagia is a common sequela of Parkinson disease (PD) and is associated with
malnutrition, aspiration pneumonia, and mortality. This review article synthesized evidence …

Abstract Purpose of Review This review summarizes the evidence on rehabilitation for
people with Parkinson's disease, including when to refer, what rehabilitation professionals …

Aims We performed cell and animal experiments to explore the therapeutic effect of
artemisinin on Parkinson's disease (PD) and the TLR4/Myd88 signaling pathway. Methods …

Parkinson's disease (PD) is a neurodegenerative disorder that affects> 1% of individuals
worldwide and is manifested by motor symptoms such as tremor, rigidity, and bradykinesia …

Delivering healthcare to people living with Parkinson's disease (PD) may be challenging in
face of differentiated care needs during a PD journey and a growing complexity. In this …